Publicaciones científicas

Development and characterization of a non-human primate model of disseminated synucleinopathy

15-dic-2023 | Revista: BiorXiv

Alberto J. Rico,  View ORCID ProfileAlmudena Corcho,  View ORCID ProfileJulia Chocarro,  View ORCID ProfileGoiaz Ariznabarreta,  View ORCID ProfileElvira Roda,  View ORCID ProfileAdriana Honrubia,  View ORCID ProfilePatricia Arnaiz,  View ORCID ProfileJosé L. Lanciego


The presence of a widespread cortical synucleinopathy is the main neuropathological hallmark underlying clinical entities such as Parkinson’s disease with dementia (PDD) and dementia with Lewy bodies (DLB). There currently is a pressing need for the development of non-human primate (NHPs) models of PDD and DLB to further overcome existing limitations in drug discovery. Here we took advantage of a retrogradely-spreading adeno-associated viral vector serotype 9 coding for the alpha-synuclein A53T mutated gene to induce a widespread synucleinopathy of cortical and subcortical territories innervating the putamen. Four weeks post-AAV deliveries animals were sacrificed and a comprehensive biodistribution study was conducted, comprising the quantification of neurons expressing alpha-synuclein, rostrocaudal distribution and their specific location.

In brief, cortical afferent systems were found to be the main contributors to putaminal afferents (superior frontal and precentral gyrus in particular), together with neurons located in the caudal intralaminar nuclei and in the substantia nigra pars compacta (leading to thalamostriatal and nigrostriatal projections, respectively). Obtained data extends current models of synucleinopathies in NHPs, providing a reproducible platform enabling the adequate implementation of end-stage preclinical screening of new drugs targeting alpha-synuclein.